# Arrivobioventuresllc

**Canonical:** https://apis.io/providers/arrivobioventuresllc/  
**Website:** https://arrivobio.com  
**APIs profiled:** 1

Arrivobioventuresllc, operating as Arrivo BioVentures, is a holding company overseeing Sirtsei Pharmaceuticals and Panafina Inc., developing innovative medicines such as SP-624 for major depressive disorder and RABI-767 for severe acute pancreatitis. The company focuses on delivering meaningful health outcomes through advanced drug candidates and expanded access programs.

## Kin Score — 4.8 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0. Trend: flat (+0.0 from 4.8).

| Facet | Score |
|---|---|
| Discoverability | 58.9 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 4.7 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## APIs (1)

- **Arrivo Bio API** — API surface discovered via host api.arrivobio.com but no machine-readable spec found.

## Security (1)

- **Arrivobioventuresllc Domain Security** — TLSv1.3 · DMARC

## Tags

Biotechnology, Pharmaceuticals, Holding Company, Clinical Trials, Mental Health

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/arrivobioventuresllc/). Scores are computed from the provider's own public artifacts under a published rubric.